Dan Theodorescu

Active 1990–2025

140
Papers
25,605
Citations
86
h-index
137
i10-index

Citations

Citations per year for Dan Theodorescu1974: 1 citations1978: 1 citations1986: 1 citations1990: 2 citations1991: 2 citations1992: 11 citations1993: 10 citations1994: 7 citations1995: 8 citations1996: 8 citations1997: 10 citations1998: 12 citations1999: 18 citations2000: 22 citations2001: 31 citations2002: 42 citations2003: 48 citations2004: 60 citations2005: 70 citations2006: 58 citations2007: 77 citations2008: 132 citations2009: 127 citations2010: 156 citations2011: 151 citations2012: 197 citations2013: 266 citations2014: 372 citations2015: 389 citations2016: 443 citations2017: 321 citations2018: 311 citations2019: 911 citations2020: 980 citations2021: 907 citations2022: 724 citations2023: 553 citations2024: 1,014 citations2025: 464 citations2026: 27 citations1975–1977: no citations, so these years are not shown1979–1985: no citations, so these years are not shown1987–1989: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,135 citing papers, 26% of this breakdownChina: 1,631 citing papers, 13.5% of this breakdownUnited Kingdom: 710 citing papers, 5.9% of this breakdownGermany: 709 citing papers, 5.9% of this breakdownItaly: 565 citing papers, 4.7% of this breakdownFrance: 428 citing papers, 3.5% of this breakdownCanada: 377 citing papers, 3.1% of this breakdownSpain: 368 citing papers, 3.1% of this breakdownJapan: 347 citing papers, 2.9% of this breakdownNetherlands: 329 citing papers, 2.7% of this breakdownAustralia: 292 citing papers, 2.4% of this breakdownSouth Korea: 221 citing papers, 1.8% of this breakdown
0%26%Other 24.5%

Fields

  • Biochemistry, Genetics and Molecular Biology49.3%
  • Medicine40.8%
  • Immunology and Microbiology3%
  • Chemistry1.9%
  • Engineering1.5%
  • Computer Science1%
  • Other2.5%

Topics

  • Cancer Genomics and Diagnostics8.7%
  • Bladder and Urothelial Cancer Treatments4.1%
  • Cancer Cells and Metastasis3.2%
  • Epigenetics and DNA Methylation3%
  • MicroRNA in disease regulation2.1%
  • Extracellular vesicles in disease2%
  • Other76.9%

Coauthors

All papers

Open in search
  1. Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Calogero Lauricella, Michael Lim, Evan J. Lipson, Suely Kazue Nagahashi Marie, George J. Netto, Kelly S. Oliner, Alessandro Olivi, Louise Olsson, Gregory J. Riggins, Andrea Sartore‐Bianchi, Kerstin Schmidt, le-Ming Shih, Sueli Mieko Oba‐Shinjo, Salvatore Siena, Dan Theodorescu, Jeanne Tie, Timothy T. Harkins, Silvio Veronese, Tian‐Li Wang, Jon Weingart, Christopher L. Wolfgang, Laura D. Wood, Dongmei Xing, Ralph H. Hruban, Jian Wu, Peter J. Allen, C. Max Schmidt, Michael A. Choti, Victor E. Velculescu, Kenneth W. Kinzler, Bert Vogelstein, Nickolas Papadopoulos, Luis A. Díaz - Science Translational Medicine 2014 cited by 5,110

  2. Advances in bladder cancer biology and therapy

    Authors: , , , , - Nature reviews. Cancer 2020 cited by 794

  3. Bladder cancer

    Authors: , , , , , , - Nature Reviews Disease Primers 2023 cited by 480

  4. The multiMiR R package and database: integration of microRNA–target interactions along with their disease and drug associations

    Authors: , , , , , , , , , , - Nucleic Acids Research 2014 cited by 774

  5. Y chromosome loss in cancer drives growth by evasion of adaptive immunity

    Authors: , , , , , , - Nature 2023 cited by 178

  6. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ming Zhang, Roger E. McLendon, Darell D. Bigner, Kenneth W. Kinzler, Bert Vogelstein, Nickolas Papadopoulos, Hai Yan - National Academy of Sciences, Proceedings of the National Academy of Sciences 2013 cited by 1,375

  7. An N-Cadherin 2 expressing epithelial cell subpopulation predicts response to surgery, chemotherapy and immunotherapy in bladder cancer

    Authors: , , , , , , , , , , , - Nature Communications 2021 cited by 177

  8. Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapy

    Authors: , , , , , , , , , , , , - Communications Biology 2020 cited by 172

  9. The Molecular Twin artificial-intelligence platform integrates multi-omic data to predict outcomes for pancreatic adenocarcinoma patients

    Authors: , , , , , , , , , , , , , - Nature Cancer 2024 cited by 83

  10. The dynamic roles of the bladder tumour microenvironment

    Authors: , , , , , - Nature Reviews Urology 2022 cited by 110

  11. Non–muscle-invasive bladder cancer molecular subtypes predict differential response to intravesical Bacillus Calmette-Guérin

    Authors: , , , , , , , , , , , , , - Science Translational Medicine 2023 cited by 85

  12. Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael Melter, Christian Neusüß, Jan Novák, Karlheinz Peter, Kasper Rossing, Harald Rupprecht, Joost P. Schanstra, Eric Schiffer, Jens‐Uwe Stolzenburg, Lise Tarnow, Dan Theodorescu, Visith Thongboonkerd, Raymond Vanholder, Eva M. Weissinger, Harald Mischak, Philippe Schmitt‐Kopplin - Molecular & Cellular Proteomics 2010 cited by 538

  13. Cellular Disposal of miR23b by RAB27-Dependent Exosome Release Is Linked to Acquisition of Metastatic Properties

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Cancer Research 2014 cited by 297

  14. Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dafei Feng, Jing Chen, Song Wu, Jing Zou, Zhang Zhong-fu, Ruilin Yang, Jun Zhao, Congjie Xu, Weihua Yin, Zhichen Guan, Jiongxian Ye, Hong Zhang, Jingxiang Li, Karsten Kristiansen, Michael L. Nickerson, Dan Theodorescu, Yingrui Li, Xiuqing Zhang, Songgang Li, Jian Wang, Huanming Yang, Jun Wang, Zhiming Cai, Jun Wang, Zhiming Cai - Nature Genetics 2011 cited by 764

  15. A Carcinogen-induced mouse model recapitulates the molecular alterations of human muscle invasive bladder cancer

    Authors: , , , , , , , , , , , , , , , , , , , , - Oncogene 2018 cited by 197

  16. TRIM28 is a transcriptional activator of the mutant TERT promoter in human bladder cancer

    Authors: , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2021 cited by 60

  17. Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Zhibo Gao, Jingxiao Lu, Yuan Yu, Chunxiao Liu, Lin Li, Xiaodong Fang, Zhimao Jiang, Jie Yang, Cailing Li, Xin Zhao, Jing Chen, Fang Zhang, Yongqi Lai, Zheguang Lin, Fangjian Zhou, Hao Chen, Hsiao Chang Chan, Shirley Tsang, Dan Theodorescu, Yingrui Li, Xiuqing Zhang, Jian Wang, Huanming Yang, Yaoting Gui, Jun Wang, Zhiming Cai, Jun Wang, Zhiming Cai - Nature Genetics 2013 cited by 512

  18. TERT promoter mutations and telomerase reactivation in urothelial cancer

    Authors: , , , , , , , , - Science 2015 cited by 296

  19. Targeting DDR2 enhances tumor response to anti–PD-1 immunotherapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Science Advances 2019 cited by 127

  20. A Randomized Phase II Study of Coexpression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Bladder Cancer (SWOG S1314; NCT02177695)

    Authors: , , , , , , , , , , , , , , , , - Clinical Cancer Research 2021 cited by 91

  21. Assessment of Luminal and Basal Phenotypes in Bladder Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , - Scientific Reports 2020 cited by 171

  22. Recommendations for Biomarker Identification and Qualification in Clinical Proteomics

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Theo M. Luider, Ziad A. Massy, William B. Mattes, Franck Molina, Bernard Monsarrat, Jan Novák, Karlheinz Peter, Peter Rossing, Marta Sänchez‐Carbayo, Joost P. Schanstra, O. John Semmes, Goce Spasovski, Dan Theodorescu, Visith Thongboonkerd, Raymond Vanholder, Timothy D. Veenstra, Eva M. Weissinger, Tadashi Yamamoto, Antonia Vlahou - Science Translational Medicine 2010 cited by 335

  23. Adenosine A2B Receptor Blockade Slows Growth of Bladder and Breast Tumors

    Authors: , , , , , - The Journal of Immunology 2011 cited by 202

  24. Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancers

    Authors: , , , , - Genes & Development 2015 cited by 195